CAROLINA REGIONAL CANCER CENTER ANNOUNCES PILOT PROGRAM FOR ADAPTIVE TREATMENT PLANNING TO FURTHER EXPAND THE BENEFITS OF ITS TOMOTHERAPY HI•ART TREATMENT SYSTEM

Carolina Regional Cancer Center (CRCC), an affiliate of MUSC Hollings Cancer Center, has initiated a Pilot Program to study the benefits of Adaptive Treatment Planning utilizing the TomoTherapy® Hi•Art® Treatment System, one of the most effective forms of radiation treatment available.  Adaptive tr... [read more]

CAROLINA REGIONAL CANCER CENTER WELCOMES NEWS AS AFFILIATE, MUSC HOLLINGS CANCER CENTER, RECEIVES PRESTIGIOUS DESIGNATION BY NATIONAL CANCER INSTITUTE

Carolina Regional Cancer Center (CRCC), affiliated with the Medical University of South Carolina (MUSC) Hollings Cancer Center (HCC), announced today that HCC recently received designation by the National Cancer Institute (NCI) as one of the top cancer research centers in the country. HCC is one of only 64 other can... [read more]

Prostate Cancer Treatment

There are two gold standard, state-of-the-art curative treatments for prostate cancer.
There is 1) a surgical procedure known as a radical prostatectomy, in which the prostate is removed by a urologic surgeon and 2) conformal radiation treatment, at its highest evolution delivered by intensity-modulation. External beam radiation is sometimes supplemented by a boost of radioactive seeds.

Here at Carolina Regional Cancer Center, we have specialized for several years in delivery of high-dose, high-energy conformal radiation treatment planned and delivered in three dimensions so as to encompass the prostate gland isovolumetrically with an extremely small and precise margin around the gland itself, while sparing the surrounding normal tissues such as the bladder and the rectum from significant doses of radiation.

We have utilized the three-dimensional capabilities of our equipment and staff since the equipment first obtained FDA approval about seven years ago.